Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-14
2007-08-14
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S373100
Reexamination Certificate
active
11567039
ABSTRACT:
The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine
REFERENCES:
patent: 5264451 (1993-11-01), Kees
patent: 5274111 (1993-12-01), Kees
patent: 6815428 (2004-11-01), Ohsumi et al.
patent: 6908905 (2005-06-01), Ohsumi et al.
patent: 2005/0043249 (2005-02-01), Ohsumi et al.
patent: 0 850 946 (1998-07-01), None
patent: 1 213 296 (2002-06-01), None
patent: 2003-012686 (2003-01-01), None
patent: WO 01/16147 (2001-03-01), None
patent: WO 02/053573 (2002-07-01), None
patent: WO 02/068439 (2002-09-01), None
patent: WO 02/088157 (2002-11-01), None
Kenneth L. Kees et al, “New Potent Antihyperglycemic Agents in db/db Mice: Synthesis and Structure-Activity Relationship Studies of (4-Substituted benzyl)(trifluoromethyl)pyrazoles and -pyrazolones”,J. Med. Chem., 1996, 39, pp. 3920-3928.
Kenji Tsujihara et al, “Na+-Glucose Cotransporter (SGLT) Inhibitors as Antidiabetic Agents. 4. Synthesis and Pharmacological Properties of 4′-Dehydroxyphlorizin Derivatives Substituted on the B Ring”,J. Med. Chem., 1999, 42, pp. 5311-5324.
Hatanaka Toshihiro
Kageyama Yoko
Kondo Nobuo
Maezono Katsumi
Matsueda Hiroyuki
Ajinomoto Co. Inc.
Saeed Kamal A.
LandOfFree
Pyrazole derivatives and diabetic medicine containing them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivatives and diabetic medicine containing them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives and diabetic medicine containing them will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828203